| Active Not Recruiting | Abemaciclib and Letrozole to Treat Endometrial Cancer Endometrial Cancer | Phase 2 | 2020-10-10 |
| Active Not Recruiting | Ribociclib and Letrozole Treatment in Ovarian Cancer Low Grade Serous Carcinoma | Phase 2 | 2019-05-20 |
| Withdrawn | Pazopanib for Treating Uterine Leiomyosarcoma Uterine Leiomyosarcoma | Phase 2 | 2015-03-01 |
| Unknown | Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma | Phase 2 / Phase 3 | 2014-03-17 |
| Completed | Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cav Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma | Phase 2 | 2012-11-05 |
| Completed | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma | Phase 2 | 2012-09-01 |
| Completed | Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage II Lymphedema, Perioperative/Postoperative Complications, Stage IA Vulvar Cancer AJCC v7 | Phase 2 | 2012-07-16 |
| Completed | EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent O Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma | Phase 1 | 2012-07-09 |
| Unknown | Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamou Stage III Vulvar Cancer AJCC v7, Stage IIIA Vulvar Cancer AJCC v7, Stage IIIB Vulvar Cancer AJCC v7 | Phase 2 | 2012-07-02 |
| Unknown | Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma | Phase 3 | 2012-06-18 |
| Terminated | Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patie Stage I Uterine Sarcoma AJCC v7, Uterine Corpus Leiomyosarcoma | Phase 3 | 2012-06-04 |
| Unknown | Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Lymphedema, Stage IA Cervical Cancer, Stage IA Uterine Corpus Cancer | N/A | 2012-06-01 |
| Withdrawn | Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithe Fatigue, Malignant Ovarian Mixed Epithelial Tumor, Neuropathy | Phase 3 | 2012-04-01 |
| Unknown | Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection Stage I Vulvar Cancer, Stage II Vulvar Cancer, Stage III Vulvar Cancer | — | 2012-01-03 |
| Completed | Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma | Phase 2 | 2011-10-01 |
| Unknown | Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovar Stage I Ovarian Cancer AJCC v6 and v7, Stage IA Fallopian Tube Cancer AJCC v6 and v7, Stage IB Fallopian Tube Cancer AJCC v6 and v7 | — | 2011-08-15 |
| Completed | Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma | Phase 2 | 2011-06-06 |
| Terminated | Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma | N/A | 2011-06-01 |
| Completed | Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Phase 2 | 2011-05-23 |
| Unknown | Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, Anxiety, Fatigue, Nausea and Vomiting | — | 2011-04-12 |
| Unknown | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Phase 1 | 2011-04-04 |
| Completed | Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Phase 2 | 2011-04-04 |
| Completed | Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Perit Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma | — | 2011-03-01 |
| Completed | TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients Wit Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma | Phase 1 | 2011-03-01 |
| Withdrawn | Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-01 Fallopian Tube Carcinoma, Hereditary Breast and Ovarian Cancer Syndrome, Ovarian Carcinoma | — | 2011-01-01 |
| Completed | EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, o Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | 2010-11-01 |
| Completed | Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma | Phase 2 | 2010-10-01 |
| Completed | Prognostic Biomarkers in Patients With Endometrial Cancer Endometrial Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer | — | 2010-09-01 |
| Unknown | Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stag Endometrial Cancer | — | 2010-07-01 |
| Completed | OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer | Phase 2 | 2010-07-01 |
| Completed | Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Pa Recurrent Cervical Carcinoma, Recurrent Uterine Corpus Carcinoma, Recurrent Uterine Corpus Sarcoma | — | 2010-07-01 |
| Completed | Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Neoplasm | — | 2010-06-07 |
| Unknown | Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer Endometrial Cancer | — | 2010-05-01 |
| Completed | Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone Cognitive Side Effects of Cancer Therapy, Malignant Ovarian Epithelial Tumor, Ovarian Brenner Tumor | — | 2010-04-01 |
| Unknown | Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer Cervical Cancer | — | 2010-02-01 |
| Unknown | Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | — | 2010-02-01 |
| Unknown | Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Psychological Impact of Cancer | N/A | 2010-01-19 |
| Completed | Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer | — | 2010-01-01 |
| Completed | Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | — | 2010-01-01 |
| Withdrawn | Biomarkers in Samples From Patients With Endometrial Cancer Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer | — | 2010-01-01 |
| Completed | Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer | — | 2010-01-01 |
| Completed | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma | Phase 2 | 2009-07-06 |
| Completed | A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor | Phase 2 | 2009-07-01 |
| Unknown | Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IA Uterine Corpus Cancer AJCC v7 | Phase 3 | 2009-06-29 |
| Unknown | Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patient Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue | Phase 3 | 2009-03-23 |
| Completed | Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma | Phase 2 | 2009-02-01 |
| Completed | Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithe Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma, Fallopian Tube Carcinoma | Phase 1 | 2009-02-01 |
| Completed | Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Cervical Cancer | Phase 2 | 2008-09-01 |
| Completed | A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithel Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma | Phase 2 | 2008-06-01 |
| Withdrawn | Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Breast Carcinoma | — | 2008-05-01 |
| Unknown | Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer | — | 2008-04-01 |
| Completed | Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer Ovarian Carcinoma | Phase 2 | 2008-03-10 |
| Completed | Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian E Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2008-03-01 |
| Unknown | Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171 Cervical Cancer, Precancerous Condition | — | 2008-02-01 |
| Completed | Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV En Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma | Phase 1 | 2008-01-17 |
| Terminated | AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2007-12-01 |
| Terminated | Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extr Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer | Phase 3 | 2007-12-01 |
| Completed | Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Complete Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor, Partial Hydatidiform Mole | Phase 2 | 2007-10-09 |
| Withdrawn | Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma | N/A | 2007-10-01 |
| Terminated | YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Fallopian Tube Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | — | 2007-09-01 |
| Completed | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer | Phase 1 | 2007-09-01 |
| Terminated | Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia High Grade Squamous Intraepithelial Neoplasia, Stage 0 Uterine Corpus Cancer | Phase 2 | 2007-07-01 |
| Completed | Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovari Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | 2007-06-01 |
| Completed | Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus Sarcoma | Phase 2 | 2007-06-01 |
| Completed | Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Squamous Cell Carcinoma, Recurrent Cervical Carcinoma | Phase 2 | 2007-06-01 |
| Completed | Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fall Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2007-05-01 |
| Completed | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing S Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma | — | 2007-04-02 |
| Completed | Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2006-11-01 |
| Completed | ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma | Phase 2 | 2006-11-01 |
| Completed | Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube Carcinoma, Infectious Disorder, Neutropenia | Phase 1 | 2006-06-01 |
| Completed | Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer Endometrial Cancer | Phase 2 | 2006-05-01 |
| Withdrawn | Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Prima Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2006-04-01 |
| Completed | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma | Phase 2 | 2006-01-01 |
| Completed | Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remov Hereditary Breast and Ovarian Cancer Syndrome, Osteoporosis, Ovarian Carcinoma | Phase 2 | 2005-11-28 |
| Unknown | Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Fallopian Tube Cancer, Ovarian Cancer | N/A | 2005-10-01 |
| Terminated | Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor Gestational Trophoblastic Tumor | Phase 2 | 2005-07-01 |
| Completed | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Cervical Carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3, Stage 0 Cervical Cancer | Phase 2 | 2005-06-01 |
| Completed | Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Can Sarcoma | Phase 2 | 2005-05-01 |
| Completed | Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma | Phase 2 | 2005-03-01 |
| Completed | Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer Cervical Cancer | Phase 2 | 2005-02-01 |
| Completed | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva Stage III Vulvar Cancer, Stage IVB Vulvar Cancer, Vulvar Squamous Cell Carcinoma | Phase 2 | 2005-01-01 |
| Completed | Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Can Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma | Phase 2 | 2005-01-01 |
| Completed | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma | Phase 1 | 2005-01-01 |
| Completed | Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2005-01-01 |
| Completed | Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Cervical Cancer | Phase 2 | 2004-09-01 |
| Recruiting | Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovar Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer | — | 2004-09-01 |
| Unknown | Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7 | Phase 2 | 2004-08-30 |
| Completed | Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix Cervical Cancer | Phase 2 | 2004-08-01 |
| Completed | Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2004-07-01 |
| Completed | Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) Endometrial Cancer | Phase 2 | 2004-07-01 |
| Terminated | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma | N/A | 2004-06-01 |
| Completed | Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2004-06-01 |
| Completed | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation | Phase 2 | 2004-04-01 |
| Terminated | Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epitheli Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2004-04-01 |
| Completed | Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent Sarcoma | Phase 2 | 2003-12-01 |
| Completed | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma | Phase 1 | 2003-10-01 |
| Completed | Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ova Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma | Phase 1 | 2003-09-01 |
| Completed | Vaginal Changes and Sexual Function in Patients With Cervical Cancer Cervical Cancer, Sexuality and Reproductive Issues | — | 2003-07-01 |
| Completed | EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer Cervical Cancer | N/A | 2003-06-01 |
| Completed | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recu Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma | Phase 3 | 2003-05-01 |
| Completed | Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopia Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor | Phase 1 | 2003-04-01 |
| Completed | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy | Phase 3 | 2003-03-01 |
| Terminated | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cer Cervical Cancer | Phase 3 | 2003-02-01 |
| Completed | Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | 2003-01-01 |
| Completed | Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer | Phase 3 | 2003-01-01 |
| Withdrawn | Research Study in Patients With Advanced Ovarian Epithelial Cancer Ovarian Serous Cystadenocarcinoma, Ovarian Serous Surface Papillary Adenocarcinoma, Stage IIIA Ovarian Cancer | — | 2002-11-01 |
| Completed | CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Canc Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma | Phase 2 | 2002-09-01 |
| Terminated | Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increa Ovarian Cancer | N/A | 2002-09-01 |
| Completed | Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Recurrent Cervical Carcinoma | Phase 2 | 2002-06-01 |
| Completed | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Recurrent Cervical Carcinoma | Phase 2 | 2002-04-29 |
| Terminated | Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus Sarcoma | Phase 2 | 2002-03-01 |
| Terminated | Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix Cervical Cancer | Phase 2 | 2001-12-01 |
| Completed | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Ane Anemia, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 3 | 2001-08-01 |
| Completed | Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Ca Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2001-08-01 |
| Terminated | Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2001-07-01 |
| Completed | Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer Endometrial Cancer | Phase 2 | 2001-07-01 |
| Completed | Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Pe Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2001-06-01 |
| Terminated | Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stag Endometrial Cancer | Phase 3 | 2001-05-01 |
| Completed | Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Cervical Cancer | Phase 2 | 2001-04-01 |
| Terminated | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer o Vulvar Cancer | Phase 3 | 2001-03-01 |
| Terminated | Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2001-03-01 |
| Completed | Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Th Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2001-01-01 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Primary Peritoneal Carcinoma, Stage III Ovarian Cancer, Stage IV Ovarian Cancer | Phase 3 | 2001-01-01 |
| Completed | Paclitaxel in Treating Patients With Ovarian Stromal Cancer Adult Type Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor | Phase 2 | 2000-11-20 |
| Terminated | Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix Cervical Cancer | Phase 2 | 2000-10-01 |
| Terminated | Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix Cervical Cancer | Phase 2 | 2000-09-01 |
| Completed | Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer Endometrial Cancer | Phase 2 | 2000-08-01 |
| Completed | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma | Phase 3 | 2000-07-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Ca Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma | Phase 1 | 2000-07-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Ca Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer | Phase 1 | 2000-07-01 |
| Completed | Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer Endometrial Cancer | Phase 2 | 2000-05-01 |
| Completed | Chemotherapy in Treating Patients With Sarcoma of the Uterus Endometrial Cancer, Sarcoma | Phase 2 | 2000-05-01 |
| Completed | Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 2000-04-01 |
| Completed | Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer Cervical Cancer | Phase 2 | 2000-02-01 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Periton Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 2000-02-01 |
| Terminated | Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2000-02-01 |
| Completed | Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2000-02-01 |
| Completed | Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva Vulvar Cancer | Phase 3 | 1999-12-01 |
| Completed | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Cervical Cancer | Phase 1 / Phase 2 | 1999-11-01 |
| Completed | Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer Endometrial Cancer | Phase 2 | 1999-11-01 |
| Completed | Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix Cervical Cancer | Phase 1 | 1999-11-01 |
| Terminated | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma | Phase 2 | 1999-11-01 |
| Completed | Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Gestational Trophoblastic Tumor | Phase 2 | 1999-10-01 |
| Completed | Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 1999-09-01 |
| Completed | Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer Endometrial Cancer | Phase 2 | 1999-08-01 |
| Terminated | Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer Ovarian Cancer | Phase 2 | 1999-07-01 |
| Completed | Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervic Cervical Cancer | Phase 3 | 1999-06-01 |
| Completed | Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia Good Prognosis Metastatic Gestational Trophoblastic Tumor, Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor | Phase 3 | 1999-06-01 |
| Terminated | Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Ovarian Cancer | — | 1999-04-01 |
| Completed | Quality of Life in Survivors of Gynecologic Cancer Endometrial Cancer, Ovarian Cancer | — | 1999-04-01 |
| Completed | Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 1999-03-01 |
| Completed | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cance Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 1999-01-01 |
| Completed | Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent End Endometrial Cancer | Phase 3 | 1998-12-01 |
| Terminated | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cance Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer | Phase 2 | 1998-12-01 |
| Terminated | Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer Endometrial Cancer | Phase 2 | 1998-11-01 |
| Completed | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stag Ovarian Cancer | Phase 3 | 1998-10-01 |
| Completed | Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer Precancerous Condition, Stage 0 Cervical Cancer | N/A | 1998-09-01 |
| Terminated | Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus Sarcoma | Phase 2 | 1998-08-01 |
| Terminated | Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Prima Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 1998-08-01 |
| Terminated | Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus Sarcoma | Phase 2 | 1998-06-01 |
| Terminated | Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 1998-06-01 |
| Terminated | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 1998-05-01 |
| Terminated | Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recur Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | 1998-05-01 |
| Completed | Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | 1998-03-01 |
| Completed | Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of t Sarcoma | Phase 3 | 1997-11-01 |
| Completed | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix Cervical Cancer | Phase 3 | 1997-10-01 |
| Terminated | Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus Sarcoma | Phase 2 | 1997-08-01 |
| Completed | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer Cervical Cancer | Phase 2 | 1997-08-01 |
| Terminated | Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus Sarcoma | Phase 2 | 1997-08-01 |
| Terminated | Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer Endometrial Cancer | Phase 3 | 1997-06-01 |
| Completed | Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer Cervical Cancer | Phase 3 | 1996-12-01 |
| Terminated | Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Ovarian Cancer | Phase 3 | 1996-11-01 |
| Completed | Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus Endometrial Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage I Uterine Sarcoma | Phase 3 | 1996-04-01 |
| Completed | Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | 1996-03-01 |
| Completed | Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer Ovarian Cancer | Phase 3 | 1994-06-01 |
| Completed | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer Cervical Cancer, Vaginal Cancer | Phase 2 | 1994-03-01 |
| Completed | Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus Sarcoma | Phase 3 | 1993-12-01 |
| Completed | Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 1993-09-01 |
| Terminated | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer Cervical Cancer, Ovarian Cancer | Phase 2 | 1993-06-01 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor, Cervical Adenocarcinoma | — | 1992-06-01 |
| Completed | Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment | Phase 3 | 1992-05-01 |
| Completed | Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Can Cervical Cancer | Phase 2 | — |
| Withdrawn | Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tu Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | — |
| Completed | Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | — |
| Completed | Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin L Vulvar Cancer | Phase 3 | — |
| Withdrawn | Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Tri Ovarian Cancer | N/A | — |
| Completed | SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer Cervical Cancer | Phase 2 | — |
| Withdrawn | Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal C Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | — |